Sun Pharma Q4 net profit zooms over two-fold to Rs 894.15 cr
Drug major Sun Pharmaceutical Industries on Thursday reported an over two-fold jump in consolidated net profit to Rs 894.15 crore for the quarter ended March 2021, mainly on account of robust performance in the Indian market. The company had posted a net profit of Rs 399.84 crore in the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing. Read here
Row escalates, govt says Twitter defaming India
The row over Twitter's handling of certain messages escalated into an all-out war of words